|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date02 May 2006 |
中国真实世界中使用存达®(盐酸苯达莫司汀)治疗惰性非霍奇金淋巴瘤的有效性和安全性研究
[Translation] A real-world study of the efficacy and safety of Cundam® (bendamustine hydrochloride) in the treatment of indolent non-Hodgkin's lymphoma in China
中国真实世界中使用存达®(盐酸苯达莫司汀)治疗惰性非霍奇金淋巴瘤的有效性和安全性研究
[Translation] A real-world study of the efficacy and safety of Cundam® (bendamustine hydrochloride) in the treatment of indolent non-Hodgkin's lymphoma in China
/ Not yet recruitingPhase 2 Randomised, double-blind study to demonstrate therapeutic equivalence of formoterol fumarate 12µg capsules delivered by Cyclohaler with Foradil in mild to moderate reversible obstructive airways disease.
100 Clinical Results associated with Pharmachemie BV
0 Patents (Medical) associated with Pharmachemie BV
100 Deals associated with Pharmachemie BV
100 Translational Medicine associated with Pharmachemie BV